A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity

por Peltonen, Karita, Colis, Laureen, Liu, Hester, Trivedi, Rishi, Moubarek, Michael S., Moore, Henna M., Bai, Bayoan, Rudek, Michelle A., Bieberich, Charles J., Laiho, Marikki
Publicado 2014

Effective targeting of RNA polymerase I in treatment-resistant prostate cancer

por Low, Jin-Yih, Sirajuddin, Paul, Moubarek, Michael, Agarwal, Shreya, Rege, Apurv, Guner, Gunes, Liu, Hester, Yang, Zhiming, De Marzo, Angelo M., Bieberich, Charles, Laiho, Marikki
Publicado en Prostate (2019)

Combined MYC activation and Pten loss are sufficient to create genomic instability and lethal metastatic prostate cancer

por Hubbard, Gretchen K., Mutton, Laura N., Khalili, May, McMullin, Ryan P., Hicks, Jessica L., Bianchi-Frias, Daniella, Horn, Lucas A., Kulac, Ibrahim, Moubarek, Michael S., Nelson, Peter S., Yegnasubramanian, Srinivasan, De Marzo, Angelo M., Bieberich, Charles J.
Publicado en Cancer Res (2015)